Amedeo Smart

Free Medical Literature Service


 

Amedeo

Ovarian Neoplasms

  Free Subscription

19.02.2024

1 BMC Cancer
1 Br J Cancer
1 Gynecol Oncol
1 Int J Cancer
3 Int J Gynaecol Obstet
1 Int J Gynecol Pathol
1 PLoS One



    BMC Cancer

  1. YOU Y, Yang Q
    Glycosylation-related genes mediated prognostic signature contribute to prognostic prediction and treatment options in ovarian cancer: based on bulk and single?cell RNA sequencing data.
    BMC Cancer. 2024;24:207.
    >> Share


    Br J Cancer

  2. ZHENG G, Faber MT, Wang J, Baandrup L, et al
    Low-dose aspirin use and risk of ovarian cancer: a combined analysis from two nationwide studies in Denmark and Sweden.
    Br J Cancer. 2024 Feb 12. doi: 10.1038/s41416-024-02609.
    >> Share


    Gynecol Oncol

  3. CHANG C, Cheng YY, Kamlapurkar S, White S, et al
    GPX3 supports ovarian cancer tumor progression in vivo and promotes expression of GDF15.
    Gynecol Oncol. 2024;185:8-16.
    >> Share


    Int J Cancer

  4. GIZAW M, Parkin DM, Stoter O, Bukirwa P, et al
    Ovarian cancer survival in sub-Saharan Africa by human development index and histological subtypes: A population-based registry study.
    Int J Cancer. 2024 Feb 10. doi: 10.1002/ijc.34877.
    >> Share


    Int J Gynaecol Obstet

  5. GAO C, Han Y, Fan X, Dong H, et al
    A case of unilateral sclerosing stromal tumor of the ovary in a postmenopausal female.
    Int J Gynaecol Obstet. 2023 Nov 12. doi: 10.1002/ijgo.15221.
    >> Share

  6. MA X, Xu L, Ma F, Zhang J, et al
    Whole-tumor apparent diffusion coefficient histogram analysis for preoperative risk stratification in endometrial endometrioid adenocarcinoma.
    Int J Gynaecol Obstet. 2023 Nov 4. doi: 10.1002/ijgo.15226.
    >> Share

  7. AYHAN A, Tunc M, Akilli H, Haberal N, et al
    Fertility-sparing approach to malignant ovarian germ cell tumors - Oncologic and obstetric outocome: A retrospective study.
    Int J Gynaecol Obstet. 2023 Sep 22. doi: 10.1002/ijgo.15141.
    >> Share


    Int J Gynecol Pathol

  8. KANG EY, Terzic T, Ghatage P, Woo L, et al
    TP53 as a Diagnostic Aid in the Distinction of Ovarian Mucinous Borderline Tumors From Mucinous Carcinoma.
    Int J Gynecol Pathol. 2024;43:111-122.
    >> Share


    PLoS One

  9. DING H, Hu B, Guo R
    Comprehensive analysis of single cell and bulk data develops a promising prognostic signature for improving immunotherapy responses in ovarian cancer.
    PLoS One. 2024;19:e0298125.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016